FT
First Trust Portfolios LP disclosed a 11.3% stake in HQL
First Trust Portfolios LP reported owning 11.3% of abrdn Life Sciences Investors (HQL) (3,551,582 shares) in a Schedule 13G filed Oct 14, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Oct 14, 2026
- Source
- Schedule 13G